Having an experienced medical team behind you is imperative as you face difficult decisions about treatment for liver cancer, a complex form of cancer that is hard to detect early. Levine Cancer Institute patients benefit from a nationally recognized hepatopancreaticobiliary (HPB) program. This collaborative team of fellowship-trained physicians uses minimally invasive approaches to treat cancer. The specialists include experts from many fields, including gastroenterology, hepatology, oncology, radiation oncology, interventional radiology, pathology and surgery, ensuring that every aspect of care is covered.
Using physician expertise, the Institute is able to offer a comprehensive treatment plan that covers not only standard options such as radiation therapy and chemotherapy, but also:
- Extended liver resections (surgery to remove the diseased portion of the liver)
- Minimally invasive surgery, including robotic surgery
- Radiofrequency and microwave ablation (nonsurgical techniques that kill tumor cells with heat and spare surrounding healthy tissue)
- Transarterial chemotherapy (minimally invasive procedure that delivers cancer drugs directly to the tumor site) and radioembolization (minimally invasive procedure that delivers radiation directly to the tumor site)
- Therapeutic endoscopy with endoscopic ultrasound
Ultimately, decisions about the most appropriate treatment lie with you and your physician and are based on factors such as diagnosis and staging.